Essais liés12clinical trials
VilleShanghailocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07719140

Ouvrir le site du centre

Essais cliniques associés

12
MoléculeIndication / populationPhaseNCTTitreStatut
TAK-935 Épilepsie Phase 2 NCT03650452 ELEKTRA — A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies COMPLETED
Soticlestat Épilepsie Phase 3 NCT04940624 A Study of Soticlestat as an Add-on Therapy in Children and Young Adults With Dravet Syndrome COMPLETED
Soticlestat Épilepsie Phase 2 NCT03635073 Endymion 1 — A Study of Soticlestat in Adults and Children With Rare Epilepsies TERMINATED
Soticlestat Épilepsie Phase 3 NCT05163314 A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome TERMINATED
Soticlestat Épilepsie Phase 3 NCT04938427 A Study of Soticlestat as an Add-on Therapy in Children, Teenagers, and Adults With Lennox-Gastaut Syndrome COMPLETED
Emapalumab Lupus Phase 3 NCT05001737 EMERALD — Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE COMPLETED
Skeletal muscle biopsy (residual specimen) Myopathies À vérifier NCT06101940 Chinese Multicenter Clinical Outcome Cohort Study of Myotonic Dystrophy Type 1 (C-DMCOS-DM1) ENROLLING_BY_INVITATION
High-dose prednisone Lupus Phase 4 NCT07719140 Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial) RECRUITING
LP352 Épilepsie Phase 3 NCT06660394 A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS) RECRUITING
LP352 Épilepsie Phase 3 NCT06719141 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE) ACTIVE_NOT_RECRUITING
LP352 Épilepsie Phase 3 NCT06908226 A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE) ENROLLING_BY_INVITATION
YTS109 cell Lupus Phase 1 NCT07439029 YTS109 in Pediatric Relapsed/Refractory Autoimmune Diseases NOT_YET_RECRUITING